Isaxonine Phosphate

CHEMBL1697751 Phase 4 Onaylandı Small molecule

Half-Life

—

Bioavailability

—

Protein Binding

—

Molecular Weight

235.2 g/mol

LogP

—

Phase

4

A phosphate salt form of isaxonine, a peripheral nerve regeneration agent investigated for treating neuropathies. It was withdrawn from the market due to serious liver toxicity.

Moleküler Ağırlık

235,1800 g/mol

TPSA

116,00 Å²

Pharmacokinetics (PK)

Pharmacodynamics (PD)

2D Yapı

SVG PNG

Cite this structure

Embed this structure

SMILES

CC(C)Nc1ncccn1.O=P(O)(O)O

InChI

InChI=1S/C7H11N3.H3O4P/c1-6(2)10-7-8-4-3-5-9-7;1-5(2,3)4/h3-6H,1-2H3,(H,8,9,10);(H3,1,2,3,4)

Molecular Formula

C7H14N3O4P

HBD / HBA

4 / 7

Döndürülebilir Bağlar

2

Ağır Atomlar

15

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Sıkça Sorulan Sorular

A phosphate salt form of isaxonine, a peripheral nerve regeneration agent investigated for treating neuropathies. It was withdrawn from the market due to serious liver toxicity.

Yes, Isaxonine Phosphate is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

ChEMBL — European Bioinformatics Institute (EBI). CHEMBL1697751. Open-access bioactivity database.
PubChem — National Center for Biotechnology Information (NCBI). CID 163093. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-04.

PillFYI

Hasta dostu bilgi mi arıyorsunuz?

Isaxonine Phosphate PillFYI'da

Yapı

Hızlı Veriler

Formül: C7H14N3O4P

Dış Bağlantılar

Cite

BibTeX, APA, MLA, Chicago, IEEE, Harvard

Tıbbi Sorumluluk Reddi

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.